Follicular lymphoma and macrophages: impact of approved and novel therapies

por Gouni, Sushanth, Marques-Piubelli, Mario L., Strati, Paolo
Publicado 2021

P1092: A PHASE II INVESTIGATOR INITIATED STUDY OF ACALABRUTINIB, LENALIDOMIDE AND RITUXIMAB (AR2) IN PATIENTS WITH PREVIOUSLY UNTREATED HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA

por Strati, Paolo, Feng, Lei, Westin, Jason, Nair, Ranjit, Gouni, Sushanth, Fayad, Luis, Rodriguez, Maria, Chihara, Dai, Malpica, Luis, Steiner, Raphael, Gallardo, Mariana, Nastoupil, Loretta J., Neelapu, Sattva
Publicado 2023

Rate of Progression of Aortic Stenosis in Patients With Cancer

por Bravo-Jaimes, Katia, Palaskas, Nicolas L., Banchs, Jose, Abelhad, Nadia I., Altaf, Alveena, Gouni, Sushanth, Song, Juhee, Hassan, Saamir A., Iliescu, Cezar, Deswal, Anita, Yusuf, Syed Wamique
Publicado 2021

BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified

por Marques-Piubelli, Mario L., Solis, Luisa M., Parra, Edwin R., Castillo, Luis Malpica, Gouni, Sushanth, Nair, Ranjit, Chihara, Dai, Konopleva, Marina, Wistuba, Ignacio I., Iyer, Swaminathan P., Vega, Francisco, Strati, Paolo
Publicado 2021

A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy

por Gouni, Sushanth, Rosenthal, Allison C., Crombie, Jennifer L., Ip, Andrew, Kamdar, Manali K., Hess, Brian, Feng, Lei, Watson, Grace, Ayers, Amy, Neelapu, Sattva S., Khurana, Arushi, Lin, Yi, Iqbal, Madiha, Merryman, Reid W., Strati, Paolo
Publicado 2022

PortEco: a resource for exploring bacterial biology through high-throughput data and analysis tools

por Hu, James C., Sherlock, Gavin, Siegele, Deborah A., Aleksander, Suzanne A., Ball, Catherine A., Demeter, Janos, Gouni, Sushanth, Holland, Timothy A., Karp, Peter D., Lewis, John E., Liles, Nathan M., McIntosh, Brenley K., Mi, Huaiyu, Muruganujan, Anushya, Wymore, Farrell, Thomas, Paul D.
Publicado 2014

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

por Jallouk, Andrew P., Gouni, Sushanth, Westin, Jason, Feng, Lei, Mistry, Haleigh, Steiner, Raphael E., James, Jinsu, Noorani, Mansoor, Horowitz, Sandra, Puebla-Osorio, Nahum, Fayad, Luis E., Iyer, Swaminathan P., Hawkins, Misha, Flowers, Christopher R., Ahmed, Sairah, Nastoupil, Lo retta J, Kebriaei, Partow, Shpall, Elizabeth J., Neelapu, Sattva S., Nieto, Yago, Strati, Paolo
Publicado 2022

SIRPα(+) macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab

por Marques-Piubelli, Mario L., Parra, Edwin R., Feng, Lei, Soto, Luisa Solis, Gallardo, Mariana, Gouni, Sushanth, Samaniego, Felipe, Noorani, Mansoor, Hagemeister, Fredrick B., Westin, Jason R., Lee, Hun Ju, Rodriguez, Maria A., Neelapu, Sattva S., Gunther, Jillian R., Fowler, Nathan H., Flowers, Christopher R., Wistuba, Ignacio I., Nastoupil, Loretta J., Vega, Francisco, Strati, Paolo
Publicado 2022

An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome

por Canna, Scott W., de Jesus, Adriana Almeida, Gouni, Sushanth, Brooks, Stephen R., Marrero, Bernadette, Liu, Yin, DiMattia, Michael A., Zaal, Kristien J.M., Montealegre Sanchez, Gina A., Kim, Hanna, Chapelle, Dawn, Plass, Nicole, Huang, Yan, Villarino, Alejandro V., Biancotto, Angelique, Fleisher, Thomas A., Duncan, Joseph A., O’Shea, John J, Benseler, Susanne, Grom, Alexei, Deng, Zuoming, Laxer, Ronald M, Goldbach-Mansky, Raphaela
Publicado 2014